CA2311119A1 - Method for transporting a molecular substance in predetermined areas of eucaryotic cells - Google Patents

Method for transporting a molecular substance in predetermined areas of eucaryotic cells Download PDF

Info

Publication number
CA2311119A1
CA2311119A1 CA002311119A CA2311119A CA2311119A1 CA 2311119 A1 CA2311119 A1 CA 2311119A1 CA 002311119 A CA002311119 A CA 002311119A CA 2311119 A CA2311119 A CA 2311119A CA 2311119 A1 CA2311119 A1 CA 2311119A1
Authority
CA
Canada
Prior art keywords
molecular substance
vehicle according
protein
pentamer
viral protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002311119A
Other languages
English (en)
French (fr)
Inventor
Wolf Bertling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
November AG Novus Medicatus Bertling Gesellschaft fuer Molekular Medizin
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2311119A1 publication Critical patent/CA2311119A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/22011Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002311119A 1998-06-29 1999-06-19 Method for transporting a molecular substance in predetermined areas of eucaryotic cells Abandoned CA2311119A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19829005.5 1998-06-29
DE19829005A DE19829005C2 (de) 1998-06-29 1998-06-29 Verfahren zum Transport molekularer Substanz in vorgegebene Bereiche eukaryontischer Zellen
PCT/DE1999/001805 WO2000000224A2 (de) 1998-06-29 1999-06-19 Verfahren zum transport molekularer substanz in vorgegebene bereiche eukaryontischer zellen

Publications (1)

Publication Number Publication Date
CA2311119A1 true CA2311119A1 (en) 2000-01-06

Family

ID=7872407

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002311119A Abandoned CA2311119A1 (en) 1998-06-29 1999-06-19 Method for transporting a molecular substance in predetermined areas of eucaryotic cells

Country Status (4)

Country Link
EP (1) EP1007107A2 (de)
CA (1) CA2311119A1 (de)
DE (1) DE19829005C2 (de)
WO (1) WO2000000224A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19952957B4 (de) * 1999-11-03 2006-08-31 Acgt Progenomics Ag Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1319101C (en) * 1986-09-03 1993-06-15 Marta Iris Sabara Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
CA2101735A1 (en) * 1991-02-04 1992-08-05 Mark J. Redmond Vp6 encapsulated drug delivery
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
AU705035B2 (en) * 1995-06-07 1999-05-13 Baylor College Of Medicine Nucleic acid transporters for delivery of nucleic acids into a cell
GB9607899D0 (en) * 1996-04-17 1996-06-19 Scottish Crop Research Inst Virus-like particle
DE19618797C2 (de) * 1996-05-10 2000-03-23 Bertling Wolf Vehikel zum Transport molekularer Substanz
DE19750354A1 (de) * 1997-11-13 1999-05-27 November Ag Molekulare Medizin Verfahren zur Applikation von Wirkstoffen

Also Published As

Publication number Publication date
EP1007107A2 (de) 2000-06-14
DE19829005A1 (de) 1999-12-30
WO2000000224A2 (de) 2000-01-06
DE19829005C2 (de) 2000-08-31
WO2000000224A3 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
EP1700911B1 (de) Methode zur in vitro Auseinander- und Wiederzusammensetzung von Papillomavirus virus-ähnlichen Teilchen (VLPs)
KR0178022B1 (ko) 단백질-다가양이온 결합체
Georgens et al. Recombinant virus like particles as drug delivery system
CA2856436A1 (en) Uses of myostatin antagonists
CA2224907A1 (en) Methods and means for targeted gene delivery
JP2006257088A (ja) ポリヌクレオチド送達のための組成物および方法
US7279306B2 (en) Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus L1 proteins, and uses thereof
US7351533B2 (en) In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
SUN et al. Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein
US6380364B1 (en) Chimeric biotin-binding papillomavirus protein
JP2003061693A (ja) ウイルス様粒子、その製造方法およびその使用
Günther et al. Protein and peptide delivery via engineered polyomavirus‐like particles
JP2000500020A (ja) 正十二面体様アデノウイルス・タンパク質複合体、それを含む組成物、及びその使用方法
CA2311119A1 (en) Method for transporting a molecular substance in predetermined areas of eucaryotic cells
US20230159596A1 (en) Virus-like nanoparticles for oral delivery
JP3733329B2 (ja) 分子性物質のためのモジュール式輸送系ならびにその製造方法および使用方法
JPS61500971A (ja) B型肝炎ウイルスの表面抗原と重合ヒト血清アルブミンレセプタ−とを有する粒子を含むワクチン製造に有用な組成物、前記の如き粒子を産生し得る動物細胞、並びにこれら細胞を得るための方法
EP1250593B1 (de) In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln
US6962777B1 (en) In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
JP2002500637A (ja) 遺伝物質のデリバリー用パポバウイルスカプシド蛋白質の使用
EP0969013B1 (de) Peptide zur Inhibition von HPV E7 Proteinen
Žáčková Suchanová Targeting of viral nanoparticles to cancer specific receptors
Mäkelä et al. Peptide-mediated interference with baculovirus transduction
US20030096259A1 (en) In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
JP2003513628A (ja) タンパク質シェルにおける分子性物質の定方向パッケージング方法

Legal Events

Date Code Title Description
FZDE Dead